Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects

…, O Windl, I Zerr, H Budka, N Kopp… - Annals of …, 1999 - Wiley Online Library
… Paraffin sections from formalin-fixed blocks of frontal (n 165) and occipital cortices (n 110),
as well as cerebellum (n 161) obtained from 187 brains, were processed by using the …

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a …

…, AM Staiger, M Szczepanowski, C Pott, N Kopp… - The lancet …, 2015 - thelancet.com
Background Follicular lymphoma is a clinically and genetically heterogeneous disease, but
the prognostic value of somatic mutations has not been systematically assessed. We aimed …

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

…, D Toscano, MA Lunning, N Kopp… - Blood, The Journal …, 2014 - ashpublications.org
The genetics of angioimmunoblastic T-cell lymphoma (AITL) are very poorly understood.
We defined the mutational landscape of AITL across 219 genes in 85 cases from the United …

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia

CJ Ott, N Kopp, L Bird, RM Paranal, J Qi… - Blood, The Journal …, 2012 - ashpublications.org
We investigated the therapeutic potential of JQ1, an inhibitor of the BET class of human
bromodomain proteins, in B-cell acute lymphoblastic leukemia (B-ALL). We show that JQ1 …

Chemotaxis of nonbiological colloidal rods

Y Hong, NMK Blackman, ND Kopp, A Sen, D Velegol - Physical review letters, 2007 - APS
Chemotaxis is the movement of organisms toward or away from a chemical attractant or
toxin by a biased random walk process. Here we describe the first experimental example of …

[PDF][PDF] The public repository of xenografts enables discovery and randomized phase II-like trials in mice

…, MA Kelliher, R Koch, M Konopleva, N Kopp… - Cancer cell, 2016 - cell.com
More than 90% of drugs with preclinical activity fail in human trials, largely due to insufficient
efficacy. We hypothesized that adequately powered trials of patient-derived xenografts (PDX…

IL-1β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program

…, Y Zhang, BJ Snyder, ML Zhao, N Kopp… - The Journal of …, 2006 - journals.aai.org
Loss of blood-brain barrier (BBB) integrity is believed to be an early and significant event in
lesion pathogenesis in the inflammatory demyelinating disease multiple sclerosis (MS), and …

Genetic influence on the structural variations of the abnormal prion protein

…, S Capellari, B Ghetti, N Kopp… - Proceedings of the …, 2000 - National Acad Sciences
… Accordingly, we identify three regions in PrP Sc : one N-terminal (residues 23–73) that is
invariably PK-sensitive, one C-terminal (residues 103–231) that is invariably PK-resistant, and …

Typing prion isoforms.

…, SG Chen, RB Petersen, P Gambetti, N Kopp… - 1997 - cabidigitallibrary.org
This correspondence comments on the paper by Collinge et al. [VB 67, abst. 147] and report
the findings of immunoblot analysis of brain homogenate from 97 human cases of …

Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS

MM Berger, N Kopp, C Vital, B Redl, M Aymard, B Lina - Neurology, 2000 - AAN Enterprises
Objective: To investigate the possible association of persistent enterovirus (EV) infection
with the development of ALS. Background: Although ALS is a clinically well-defined motor …